Cancer remains a leading causes of death worldwide and an elevated systemic
inflammatory response (SIR) is associated with reduced survival in patients with operable …

Perioperative adjuvant treatment and complete resection is the standard treatment for
resectable pancreatic cancer and systemic chemotherapy is standard treatment for …

BACKGROUND Predicting survival is uniquely difficult in patients with pancreatic cancer
who receive chemotherapy. The authors developed a systemic inflammation response index …

Objective: Our aim was to determine the prognostic significance of the systemic-immune-
inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific …

BACKGROUND Systemic inflammation and nutrition status play an important role in cancer
metastasis. The combined index of hemoglobin, albumin, lymphocyte, and platelet (HALP) …

Background The C-reactive protein to albumin (CRP/Alb) ratio, a novel inflammation-based
prognostic score, is associated with outcomes in septic patients. The prognostic value of …

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive
malignancies to date, largely because it is associated with high metastatic risk. Pancreatic …

Objectives Systemic inflammatory response and survival has not been evaluated as a
predictive factor of chemotherapy in metastatic pancreatic cancer. The aim of this study was …

Background Preoperative nutritional and immunological patient factors have been found to
be associated with prognostic outcomes of malignant tumors; however, the clinical …

Background and aims Several studies were conducted to explore the prognostic value of
platelet-to-lymphocyte ratio (PLR) in pancreatic cancer and have reported contradictory …